| __timestamp | Corcept Therapeutics Incorporated | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 2652041 |
| Thursday, January 1, 2015 | 36949000 | 2361587 |
| Friday, January 1, 2016 | 45240000 | 4472869 |
| Sunday, January 1, 2017 | 62416000 | 5030957 |
| Monday, January 1, 2018 | 81289000 | 4988941 |
| Tuesday, January 1, 2019 | 100359000 | 5196412 |
| Wednesday, January 1, 2020 | 105326000 | 6652774 |
| Friday, January 1, 2021 | 122356000 | 18418247 |
| Saturday, January 1, 2022 | 152848000 | 24827066 |
| Sunday, January 1, 2023 | 184259000 | 41896408 |
| Monday, January 1, 2024 | 15488619 |
Unleashing insights
In the competitive world of biotechnology, operational efficiency is key. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Corcept Therapeutics Incorporated and Opthea Limited from 2014 to 2023. Corcept Therapeutics, a leader in the field, has seen its SG&A expenses grow by over 400% during this period, peaking in 2023. This reflects their aggressive expansion and investment in operational capabilities. In contrast, Opthea Limited, a smaller player, has experienced a more modest increase of around 1,500% in SG&A expenses, indicating a strategic scaling of operations. Notably, Opthea's expenses surged significantly in 2023, suggesting a pivotal year for the company. The data for 2024 is incomplete, leaving room for speculation on future trends. This comparison highlights the diverse strategies employed by biotech firms in managing operational costs.
Comparing SG&A Expenses: Sanofi vs Opthea Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Opthea Limited
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Opthea Limited
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Opthea Limited and Mesoblast Limited